Boll Andrew

Avg. Two Year Performance

142% Avg. Purchase Return
56% Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return28%13%46%(20%)142%
Purchase Success Rate1 of 11 of 11 of 10 of 11 of 1
Average Sale Return----------
Sale Success Rate----------

Transdel Pharmaceuticals, I...

Drugs » Biotechnology

Chief Financial Officer:

Holdings: 568.09K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--